儿童喘严重程度的代谢和免疫特征
Elena Crestani1, Hani Harb1,2, Mehdi Benamar1
1Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
概括
儿童喘的严重程度与改变的代谢途径有关,包括脂质和氨基酸. 这些变化与Treg细胞功能障碍标志物相关,这表明导致严重喘的复杂机制.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 代谢学 代谢学 代谢学
背景情况:
- 喘严重程度的机制尚未完全理解.
- 由Notch4表达和GDF15水平表明的Treg细胞功能障碍与儿童的喘严重程度有关.
研究的目的:
- 为了研究不同严重程度的喘儿童的代谢和细胞因子概况.
- 为了将这些概况与Treg细胞标记物和临床结果相关联.
主要方法:
- 招募了126名患有喘的儿童和83名对照儿童.
- 在血样本上进行了非向的代谢和细胞因子分析.
- 与喘严重程度,Treg Notch4表达和并发症相关的结果.
主要成果:
- 中度/重度喘与较高的脂质 (三糖,胺) 和碳酸 (乳酸) 以及较低的氨基酸 (氨酸,氨酸) 和IFNλ相关 2/3.3.
- 特雷格诺奇4和GDF15水平与乳酸,山丁,氨酸和氨酸相关联.
- 与微生物组代谢物相关的食物过敏;过敏性鼻炎与甘油三调节失调.
结论:
- 代谢分析揭示了与喘严重程度和Treg功能障碍相关的途径.
- 不同的机制可以独立或融合地影响儿童的喘严重程度.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K


